(Q37202012)

18 August 2017

Topoisomerase II alpha mRNA and tumour cell proliferation in non-Hodgkin's lymphoma (English)

1 reference

18 August 2017

Lohri A

1

1 reference

18 August 2017

Reuter J

series ordinal

2

1 reference

18 August 2017

Gudat F

series ordinal

3

1 reference

18 August 2017

Herrmann R

series ordinal

4

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Journal of Clinical Pathology

18 August 2017

1 reference

18 August 2017

50

1 reference

18 August 2017

1

1 reference

18 August 2017

22-26

1 reference

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Topoisomerase II in multiple drug resistance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Topoisomerase II alpha expression in acute myeloid leukaemia and its relationship to clinical outcome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell line

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Nonradioactive quantification of mdr1 mRNA by polymerase chain reaction amplification coupled with HPLC.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Proliferation dependence of topoisomerase II mediated drug action

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Topoisomerase II levels during granulocytic maturation in vitro and in vivo

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=499706

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

3 September 2018

1 reference

12 December 2020

Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas

1 reference

12 December 2020

The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma

1 reference

12 December 2020

Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.50.1.22

1 reference

18 August 2017

1 reference

18 August 2017

1 reference